RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
12.63
+0.14 (1.12%)
Dec 5, 2025, 4:00 PM EST - Market closed
RxSight Stock Forecast
Stock Price Forecast
The 10 analysts that cover RxSight stock have a consensus rating of "Hold" and an average price target of $11.3, which forecasts a -10.53% decrease in the stock price over the next year. The lowest target is $8.00 and the highest is $28.
Price Target: $11.3 (-10.53%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for RxSight stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 8 | 8 | 8 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | -20.82% | Dec 2, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -28.74% | Nov 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | -20.82% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | -4.99% | Nov 6, 2025 |
| UBS | UBS | Hold Maintains $16 → $8 | Hold | Maintains | $16 → $8 | -36.66% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
131.80M
from 139.93M
Decreased by -5.81%
Revenue Next Year
137.31M
from 131.80M
Increased by 4.18%
EPS This Year
-1.09
from -0.71
EPS Next Year
-1.03
from -1.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 137.0M | 149.2M | ||
| Avg | 131.8M | 137.3M | ||
| Low | 125.0M | 127.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -2.1% | 13.2% | ||
| Avg | -5.8% | 4.2% | ||
| Low | -10.6% | -3.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.08 | -0.28 | ||
| Avg | -1.09 | -1.03 | ||
| Low | -1.09 | -1.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.